PharMerica Reports Third Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Pharmerica (PMC) Misses Q3 EPS by 7c; Guides FY16 Below Views
November 9, 2016 8:09 AM ESTPharmerica (NYSE: PMC) reported Q3 EPS of $0.44, $0.07 worse than the analyst estimate of $0.51. Revenue for the quarter came in at $512.6 million versus the consensus estimate of $530.01 million.
GUIDANCE:
Pharmerica sees FY2016 EPS of $1.84-$1.89, versus the consensus of $2.01. Pharmerica sees FY2016... More
